IL2 and psoriasis: El-Gharabawy et al. reported that combination metformin (850 mg) with topical therapy of psoriasis considerably lowered the number of T-CD4+ lymphocytes and the levels of IL-2, C-reactive protein (CRP), ceruloplasmin, ALT, and AST compared to untreated psoriasis patients [16].